D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SRNE holding history
Sorrento Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRNE overviewAll 13F holders of SRNEFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −5,106,072−100.0% | Sold out | Holders |
| Q4 2022 | 5,106,072 | $4.52M | <0.1% | +49,109+1.0% | Added | Holders |
| Q3 2022 | 5,056,963 | $7.94M | <0.1% | −824,439−14.0% | Reduced | Holders |
| Q2 2022 | 5,881,402 | $11.8M | <0.1% | −1,360,489−18.8% | Reduced | Holders |
| Q1 2022 | 7,241,891 | $16.9M | <0.1% | +4,794,841+195.9% | Added | Holders |
| Q4 2021 | 2,447,050 | $11.4M | <0.1% | −505,785−17.1% | Reduced | Holders |
| Q3 2021 | 2,952,835 | $22.5M | <0.1% | +1,142,466+63.1% | Added | Holders |
| Q2 2021 | 1,810,369 | $17.5M | <0.1% | +1,415,064+358.0% | Added | Holders |
| Q1 2021 | 395,305 | $3.27M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.